|
|
 |
|
Viewing report
|
|
|
|
Analytical Tool: Antiangiogenesis & Vascular Targeting
Bioseeker, Feb 2004
Despite important advances in understanding the molecular basis of cancer, few treatments have been devised to specifically target the known defects in tumor cells. Standard chemotherapy or radiation treatments are inherently non-selective and kill normal cells along with malignant ones. Effective future treatments depend of developing drugs that target individual abnormalities in specific tumor cells. Specially promising new drug classes under development for treatment of cancer include monoclonal antibodies and angiogenesis inhibitors.
Despite early enthusiasm for angiogenesis inhibitors as safe and effective anticancer drugs, results of several completed Phase III and Phase II trials have been disappointing. New strategies have been developed to overcome these previous mistakes. Since the early failure of drugs such as Avastin, Erbitux, SU5416, Marimastat, Endostatin and Angiostatin, new clinical trials have commenced that will define whether the anti-angiogenetic and vascular targeting strategies will hold.
'BSG Analytical Tool: Antiangiogenesis & Vascular Targeting' offers a unique tool (database and reports) for analyzing the vast amount of strategic possibilities that have emerged in anticancer antiangiogenesis and vascular targeting. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. Additionally, we have developed a CD-ROM searchable database, which is highly updated to reflect the most recent advances in the field of cancer immunotherapy development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes.
A significant advantage with our CD-ROM searchable databases is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases,our CD-ROM searchable databases gives better overview and specific search capabilities.
Our hope is that this product will assist you in your struggle of finding the right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.
'BSG Analytical Tool: Antiangiogenesis & Vascular Targeting' is based on three major parts:
- Analysis
- Information structure
- Database
Included in this advantageous package are several products already appreciated by many of our customers representing an immense value:
- New Lines of Attack in Cancer Anti-Angiogenesis
- Cancer Pipeline Valuation: Endostatin - Will Continued Effort Generate Value?
- Cancer Pipeline Valuation: VEGF Trap (Regeneron) - A Deal Worth more than $500M?
- Integrin Antagonists - Is the Industry in Despair?
- Antiangiogenesis & Vascular Targeting Database (includes several additional projects/patents to enhance competitive analysis, see below).
This tool inlcudes:
-Information on more that 100 companies active in anticancer antiangiogenesis and vascular targeting.
-Information on more than 200 clinical trials in anticancer antiangiogenesis and vascular targeting.
-Several thousands anticancer antiangiogenesis and vascular targeting related patents and applications.
-Advanced analysis of general and specific trends in the pipeline.
-Possibility of performing advanced searches suited to your individual needs
-Taking these searches a step further by generating specific and relevant tables and graphs for optimized support in your decision-making process
This tool will assist you in:
- Tracking cutting edge companies, therapies and new technologies
- Rapid identification of partners & competitors
- Laying down a comprehensive framework for further analysis of the field
- Producing presentations surrounding the development of prostate cancer therapeutics
- Identifying emerging prostate cancer products & key areas of pharmaceutical R&D
Customers who bought this item also bought
Analytical Tool - Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology
Analytical Tool: Anticancer Integrin Antagonists
Analytical Tool - Angiogenesis in Oncology
Analytical Tool: Anticancer Basal-Membrane Strategies
Competitive Outlook on Antiangiogenesis and Vascular Targeting in Oncology
R&D Update: How Can Companies Improve on Existing Antiangiogenesis Agents?
Analytical Tool - Breast Cancer
Analytical Tool - Prostate Cancer
Analytical Tool - Cancer Vaccines
Analytical Tool: Anticancer VEGF/VEGFR Blockers
Anticancer Therapeutics
Analytical Tool - Prostate Cancer: A Therapeutic & Competitive Insight
|
|
|
|
